Perioperative medicine & outcomes

Characteristics and outcome of preoperative multidisciplinary team discussions for high-risk noncardiac surgical patients in the Netherlands: a multicentre prospective observational study

Br J AnaesthPublished Prospective observational study

Authors' conclusion

Preoperative MDT discussions lead to management modifications for high-risk noncardiac surgical patients. Almost one-third of the discussed patients did not undergo surgery. The rate of postoperative adverse events was high in this selected population.

Study context

Population
Consecutive adult high-risk noncardiac surgical patients discussed in a preoperative multidisciplinary team (MDT) meeting, 9 hospitals in the Netherlands, April 2022–September 2023median age 73 yr
Participants
225 patients
Exposure
Surgery vs Nonsurgical management
  • Nonsurgical managementn = 71
Outcome
Characteristics of MDT meetings and their effect on patient outcomes
Follow-up
Up to 30 days
Methodological detailsmulticentre, nine hospitals
  • Multicentre
  • Nine hospitals

Main finding

As reported in the abstract

MDT characteristics and management modification

Selected for MDT because of doubt regarding harm-benefit ratio of proposed surgery

n=168; 75%

Selected for MDT as part of a standardised surgical pathway

n=57; 25%

Clinical management modified after MDT discussion

183

81%

Nonsurgical management after MDT discussion

71

32%

Observational data: associations, not effects.

Further findings

30-day mortality · up to 30 days

Safety

Adverse events · up to 30 days after surgery

Original publication

Characteristics and outcome of preoperative multidisciplinary team discussions for high-risk noncardiac surgical patients in the Netherlands: a multicentre prospective observational study. Br J Anaesth. Published 6 June 2025. doi:10.1016/j.bja.2025.05.004

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.